Cranial MRI in Acute Hyperammonemic Encephalopathy

被引：25

作者：

Bindu, Parayil S. ^{[1
]}

Sinha, Sanjib ^{[1
]}

Taly, Arun B. ^{[1
]}

Christopher, Rita ^{[2
]}

Kovoor, Jerry M. E. ^{[3
]}

机构：

[1] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India

[2] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bangalore 560029, Karnataka, India

[3] Natl Inst Mental Hlth & Neurosci, Dept Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India

来源：

PEDIATRIC NEUROLOGY | 2009年 / 41卷 / 02期

关键词：

ORNITHINE TRANSCARBAMYLASE DEFICIENCY; UREA CYCLE DISORDERS; CITRULLINEMIA;

D O I：

10.1016/j.pediatrneurol.2009.02.012

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Cranial magnetic resonance imaging was performed in three cases of acute hyperammonemic encephalopathy with three diverse etiologies: infantile citrullinemia, acute hepatic encephalopathy, and proximal urea cycle disorder. All three patients exhibited diffuse extensive cortical signal changes and swelling. Neurologic outcome was poor in all three cases. Knowledge of the magnetic resonance imaging findings of hyperammonemic encephalopathy may help in early diagnosis and treatment and could influence the neurologic outcome. (C) 2009 by Elsevier Inc. All rights reserved.

引用

页码：139 / 142

页数：4

共 50 条

[41] Valproate-induced hyperammonemic encephalopathy: Imaging findings on diffusion-weighted MRI
Grubben, B
De Jonghe, P
Cras, P
Demey, HE
Parizel, PM
EUROPEAN NEUROLOGY, 2004, 52 (03) : 178 - 181
[42] Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
Dill, Patricia
Datta, Alexandre N.
Weber, Peter
Schneider, Jacques
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (03) : 311 - 315
[43] VALPROATE-ASSOCIATED HYPERAMMONEMIC ENCEPHALOPATHY
Forster, C.
Cukiert, A.
Burattini, J.
Mariani, P.
Cukiert, C.
Argentoni-Baldochi, M.
Baise-Zung, C.
Mello, V.
EPILEPSIA, 2009, 50 : 73 - 73
[44] Valproic acid induced hyperammonemic encephalopathy
Bek, S.
Kasikci, T.
Tokgoz, E.
Gokcil, Z.
Odabasi, Z.
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 619 - 619
[45] Case study: acute hyperammonemic encephalopathy in an adolescent with ornithine transcarbamylase deficiency (otcd)
Grunder, Eveline
Baumgartner, Matthias
Bar, Walter
Steigert, Michael
SWISS MEDICAL WEEKLY, 2010, 140 (21-22) : 22S - 22S
[46] ValproateNon-hyperammonemic subacute encephalopathy
Reactions Weekly, 2024, 1996 (1) : 224 - 224
[47] Sunitinib-associated hyperammonemic encephalopathy
Lipe, Demis N.
Hoxha, Besim
Sahai, Sunil K.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 46 : 282 - 283
[48] Valproate-induced hyperammonemic encephalopathy
Segura-Bruna, N.
Rodriguez-Campello, A.
Puente, V.
Roquer, J.
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (01): : 1 - 7
[49] Different clinical manifestations of hyperammonemic encephalopathy
Gomceli, Y. B.
Kutlu, G.
Cavdar, L.
Sanivar, F.
Inan, L. E.
EPILEPSY & BEHAVIOR, 2007, 10 (04) : 583 - 587
[50] Valproate-associated hyperammonemic encephalopathy
Wadzinski, Jim
Franks, Ronald
Roane, David
Bayard, Max
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2007, 20 (05) : 499 - 502

← 1 2 3 4 5 →